GlassScriptPhysician profile
Curtis D Givens
NPI 1407957343
$5,187.39
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,778 · 2020: $450 · 2021: $115 · 2022: $299 · 2023: $2,036 · 2024: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,970 · Travel and Lodging: $496 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,969.60 |
| Travel and Lodging | $495.81 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,402.53 | 2019-2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $762.36 | 2019-2024 | Fasenra, Tezspire, Airsupra |
| Jazz Pharmaceuticals INC. | $395.25 | 2019-2023 | |
| Glaxosmithkline, LLC. | $304.09 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $177.88 | 2019-2023 | Uptravi, Opsumit |
| Harmony Biosciences LLC | $162.91 | 2020-2023 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.68 | 2019-2020 | |
| Genentech USA, INC. | $135.06 | 2019 | |
| Genzyme Corporation | $125.00 | 2019 | |
| Philips North America LLC | $112.47 | 2019 | |
| Grifols USA, LLC | $93.34 | 2019-2023 | Prolastin-C Liquid |
| Medtronic USA, INC. | $81.79 | 2019 | |
| Sunovion Pharmaceuticals INC. | $57.92 | 2019 | |
| United Therapeutics Corporation | $38.21 | 2019-2020 | |
| Breas Medical, INC. | $31.54 | 2024 | Vivo 45 Ls |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $23.52 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.05 | 2019 | |
| Allergan, INC. | $20.92 | 2019 | |
| Advanced Respiratory, INC | $16.05 | 2019 | |
| Merck Sharp & Dohme LLC | $16.04 | 2020 | |
| Electromed, INC. | $13.98 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.46 | 2021 | |
| Insmed, INC. | $11.54 | 2019 | |
| Mylan Specialty L.P. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Givens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.